David Olagnier

Aarhus University — Denmark

Immunology and Microbiology · Life Sciences

38h-index5.2kcitations119works3.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

interferon and immune responses(39), Viral Infections and Vectors(20), Immune Cell Function and Interaction(17), Virus-based gene therapy research(15), Inflammasome and immune disorders(15)

Publications119 total

NRF2 activators and the inhibitor of nuclear export, selinexor, restrict coronaviruses by targeting a network involving ACE2, TMPRSS2, and XPO1 through an NRF2-independent mechanism
Communications Biology·2026Open Access
A TAK1-Driven NLRP1 Inflammasome Pathway Revealed by Phosphatase-Targeting Environmental Toxins
2026Open Access
Proteolytic profiling of human plasma reveals an immunoactive complement C3 fragment
The EMBO Journal·2025· 1 citedOpen Access
Latest insights into oncolytic viro-immunotherapy with vesicular stomatitis virus
Seminars in Immunology·2025· 1 citedOpen Access
Oncolytic virotherapy: Sparking durable anti-tumor immunity through microenvironment modulation
Seminars in Immunology·2025Open Access
Sustained inflammation during human T-lymphotropic virus type 1 infection: a wildfire contributing to disease progression
Frontiers in Medicine·2025Open Access
Fragment‐Based Drug Discovery of Novel High‐affinity, Selective, and Anti‐inflammatory Inhibitors of the Keap1‐Nrf2 Protein‐Protein Interaction
Angewandte Chemie International Edition·2025· 1 citedOpen Access
Fragment‐Based Drug Discovery of Novel High‐affinity, Selective, and Anti‐inflammatory Inhibitors of the Keap1‐Nrf2 Protein‐Protein Interaction
Angewandte Chemie·2025Open Access
Oncolytic viruses in action: A successful unique case to be considered with caution
Virologie·2025Open Access
Oncolytic viruses in action: A successful unique case to be considered with caution
Virologie·2025
The 16th Annual International Oncolytic Virotherapy Conference (IOVC) in Rotterdam: For the dreamers and doers of oncolytic virotherapy
Virologie·2025
The 16th Annual International Oncolytic Virotherapy Conference (IOVC) in Rotterdam: For the dreamers and doers of oncolytic virotherapy
Virologie·2025
Dual faces of itaconate and its derivatives: exploring diverse biological functions in immunity and infectious diseases
Human Molecular Genetics·2025· 2 cited
NRF2 activators restrict coronaviruses by targeting a network involving ACE2, TMPRSS2, and XPO1
2025· 2 citedOpen Access
HSP60 controls mitochondrial ATP generation for optimal virus-specific IL-21-producing CD4 and cytotoxic CD8 memory T cell responses
Communications Biology·2024· 2 citedOpen Access
Author Correction: Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways
Nature Communications·2024Open Access
Early host defense against virus infections
Cell Reports·2024· 13 citedOpen Access
Response to the letter to editor “Clarification on Rigvir's mechanism: Interpretation of CD55 inhibition in oncolytic therapy”
Virology·2024Open Access
Structure-Guided Conformational Restriction Leading to High-Affinity, Selective, and Cell-Active Tetrahydroisoquinoline-Based Noncovalent Keap1-Nrf2 Inhibitors
Journal of Medicinal Chemistry·2024· 14 cited
Large-scale deep learning identifies the antiviral potential of PKI-179 and MTI-31 against coronaviruses
Antiviral Research·2024· 5 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

John Hiscott(20), Rongtuan Lin(12), Christian K. Holm(11), Jacob Thyrsted(7), Suraj Peri(7), Siddharth Balachandran(7), Martin R. Jakobsen(7), Søren R. Paludan(7), Bernard Pipy(7), Agnès Coste(7), Anne Louise Hansen(6), Thomas B. Poulsen(6), Anne L. Thielke(6), Julia Blay‐Cadanet(5), Manja Idorn(5), Marie B. Iversen(5), Line S. Reinert(5), Demi van der Horst(5), Cindy Chiang(5), Julien van Grevenynghe(5)